Healthcare / BiotechnologyUpdated 2026-05-10 22:07 UTC

COYA stock hub

Coya Therapeutics, Inc. has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

COYAis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

96.4M

NASDAQ

Market data

Live price

Current market quote for this ticker.

Current price

COYA

In the news

Latest news · COYA

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 12.3P50 18.4P75 33.1

Trailing P/En/a

P25 14.9P50 23.2P75 38.5

ROE-51.4

P25 -105.6P50 -46.5P75 -3.1

ROIC-30.7

P25 -63.1P50 -27.3P75 0.5

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All COYA market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

196

Groups with data

Currency

USD

Showing 196 of 196 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0001835022
Company name	Coya Therapeutics, Inc.
Country	United States
Country code	US
Cusip	22407B108
Employees	8
Employees Change	2%
Employees Change Percent	33.33
Enterprise value	$49.6M
Exchange	NASDAQ
Financial currency	USD
First seen	2026-05-09
Industry	Biotechnology
IPO Date	2022-12-29
Isin	US22407B1089
Last refreshed	2026-05-10
Market cap	$96.4M
Market cap category	Micro-Cap
Price	$4.11
Price currency	USD
Rev Per Employee	993,219.13x
Sector	Healthcare
Sic	2834
Symbol	COYA
Website	https://www.coyatherapeutics.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-22.02%
EV Sales Forward	13.6x
EV/Sales	6.24x
FCF yield	-11.14%
P/B ratio	2x
P/S ratio	12.13x
PS Forward	26.44x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	-255.05%
EBITDA Margin	-254.71%
Gross margin	-110.61%
Gross Profit	$-8.8M
Net Income	$-21.2M
Net Income Growth Years	0%
Pretax Margin	-267.1%
Profit Margin	-267.14%
Profit Per Employee	$-2.7M
ROA	-26.86
Roa5y	-40.71
ROCE	-45.98
ROE	-51.39
ROIC	-30.67

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	-31.17%
Cagr3y	-7.54%
EPS Growth Years	0
Revenue Growth	123.57x
Revenue Growth Q	202,768.8x
Revenue Growth Quarters	1x
Revenue Growth Years	1x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	$0.17
Assets	$50M
Cash	$46.8M
Current Assets	$49.9M
Current Liabilities	$5.9M
Equity	$43M
Liabilities	$6.9M
Long Term Assets	$11,227
Long Term Liabilities	$1.1M
Net Cash	$46.8M
Net Cash By Market Cap	$48.57
Net Cash Growth	22.13%
Net Debt Equity	$-1.09
Tangible Book Value	$43M
Tangible Book Value Per Share	$2.06
WACC	7.28

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	8.5
Net Working Capital	$-2.8M
Quick ratio	7.97
Working Capital	$44.1M
Working Capital Turnover	$0.19

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-9.79%
Dividend Yield	0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	-31.16%
200-day SMA	5.42
3Y total return	-20.96%
50-day SMA	4.39
50-day SMA vs 200-day SMA	50under200
All Time High	10.69
All Time High Change	-61.55%
All Time High Date	2024-03-18
All Time Low	3.21
All Time Low Change	28.04%
All Time Low Date	2023-08-18
ATR	0.25
Beta	0.55
Beta1y	1.2
Beta2y	1.26
Ch YTD	-29.14
High	4.28
High52	7.75
High52 Date	2025-10-14
High52ch	-46.97%
Low	4.06
Low52	3.71
Low52 Date	2026-03-30
Low52ch	10.78%
Ma50ch	-6.44%
Price vs 200-day SMA	-24.23%
RSI	43.19
RSI Monthly	43.62
RSI Weekly	39.71
Sharpe ratio	-0.37x
Sortino ratio	-0.45
Total Return	-9.79%
Tr YTD	-29.14
Tr1m	3.01%
Tr1w	-1.44%
Tr3m	-15.08%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Analyst Count	5
Analyst Count Top	1
Analyst Price Target Top	$14
Analyst Ratings	Strong Buy
Analyst Ratings Top	Strong Buy
Earnings EPS Estimate	$-0.39
Earnings Revenue Estimate	71,670x
Earnings Revenue Estimate Growth	-72.21x
Operating Income	$-20.3M
Operating margin	-255
Price target	$15.8
Price Target Change	$284
Price Target Change Top	$241

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	17,834,849%
Float Percent	76.03%
Shares Insiders	5.64%
Shares Institutions	25.77%
Shares Out	23,457,183
Shares Qo Q	0.06%
Shares Yo Y	9.79%
Short Float	4.33%
Short Ratio	4.91
Short Shares	3.29

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$-15M
Average Volume	140,166.45x
Bv Per Share	2.06
Ch1m	3.01
Ch1w	-1.44
Ch1y	-31.16
Ch3m	-15.08
Ch3y	-20.96
Ch6m	-28.65
Change	-2.14%
Change From Open	-2.84
Close	4.2
Days Gap	0.71
Depreciation Amortization	27,361
Dollar Volume	680,837.9
Earnings Date	2026-05-22
Earnings Time	bmo
EBIT	$-20.3M
EBITDA	$-20.2M
EPS	$-1.27
F Score	3
FCF	$-10.7M
FCF EV Yield	-21.66x
FCF Per Share	$-0.46
Financing CF	20,386,927
Fiscal Year End	December
Founded	2,020
Income Tax	$3,089
Investing CF	-1,164,602
Ipr	-17.8
Iprfo	-13.47
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2026-03-16
Last Report Date	2025-12-31
Last Split Type	Never
Last10k Filing Date	2026-03-16
Ma150	5.19
Ma150ch	-20.85%
Ma20	4.37
Ma20ch	-6.04%
Net CF	8,483,024
Next Earnings Date	2026-05-22
Open	4.23
Optionable	Yes
Position In Range	23.26
Post Close	4.11
Postmarket Change Percent	0.14
Postmarket Price	$4.12
Ppne	11,227
Price Date	2026-05-08
Ptbv Ratio	2.24
Relative Volume	1.18x
Revenue	7,945,753x
SBC By Revenue	54x
Share Based Comp	4,290,315
Tax By Revenue	0.04x
Tr6m	-28.65%
Us State	Texas
Volume	165,654
Z Score	7.34

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does COYA pay a dividend?

Capital-return profile for this ticker.

Performance

COYA stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns COYA?

Insider, institutional, and short-interest positioning.

Institutional ownership

+25.8%

Float: +76.0% of shares outstanding

Insider ownership

+5.6%

Stake held by company insiders. Higher generally signals alignment.

Negative means the company is buying back shares.

Technical

COYA momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

43.2

Neutral momentum band

Price vs 200-day MA

-24.2%

50/200-day relationship not available

Beta (5Y)

0.55

Less volatile than the market

Sharpe ratio

-0.37

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About COYA

Hub-level FAQ points readers to the deeper analysis pages.

What is the current COYA stock rating?

Coya Therapeutics, Inc. is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full COYA analysis?

The full report lives at /stocks/COYA/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for COYA?

The latest report frames COYA around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the COYA page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.